MyMD Pharmaceuticals Inc. (MYMD)
NASDAQ: MYMD
· Real-Time Price · USD
1.81
-0.01 (-0.55%)
At close: Jul 23, 2024, 9:30 PM
MyMD Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2018 |
|---|---|
| Product Revenue Revenue | 1.67M |
| Product Revenue Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|
| Rest Of World Revenue | 17.5K | 88.81K |
| Rest Of World Revenue Growth | -80.29% | n/a |
| United States Revenue | 1.56M | 1.58M |
| United States Revenue Growth | -1.09% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | n/a | 1.1M | 1.46M | 1.59M | 1.95M | 1.93M | 3.56M | 1.06M | 1.34M | 1.91M | 1.48M | 1.49M | 1.82M | 1.64M | 16.75M | 1.51M | 3.6M | 1.03M | 811.62K | 1.06M | 905.02K | 933.29K | 995.45K | 1.13M | 1.93M | 381.99K | 442.39K | 468.46K | 2.31M | 1.2M | 1.25M | 1.38M | 1.08M | 408.25K | 1.33M | 1.65M | 1.51M | 1.49M | 2.3M | 1.27M |
| Selling, General, and Administrative Revenue Growth | -100.00% | -24.38% | -7.94% | -18.58% | +0.93% | -45.74% | +236.52% | -21.00% | -29.84% | +28.94% | -0.87% | -17.93% | +10.79% | -90.20% | +1010.61% | -58.15% | +249.13% | +27.15% | -23.50% | +17.23% | -3.03% | -6.24% | -12.14% | -41.17% | +404.20% | -13.65% | -5.57% | -79.70% | +92.87% | -3.96% | -9.67% | +27.37% | +165.28% | -69.30% | -19.34% | +8.98% | +1.82% | -35.39% | +80.58% | n/a |
| Research and Development Revenue | 1.55M | 707.75K | 401.1K | 1.2M | 2.96M | 1.91M | 2.22M | 770.43K | 2.47M | 1.8M | 2.16M | 2.63M | 1.31M | 2.77M | 1.49M | -19.36K | 1.03M | 908.12K | 1.92M | 2.48M | 69.99K | 57.5K | 60.91K | 88.39K | 203.29K | 160.87K | 259.12K | 391.38K | 307.65K | 290.45K | 313.83K | 348.44K | 256.01K | 247.58K | 321.99K | 363.29K | 403.45K | 319.65K | 378.23K | 305.57K |
| Research and Development Revenue Growth | +118.44% | +76.45% | -66.55% | -59.51% | +54.86% | -14.03% | +188.67% | -68.81% | +36.99% | -16.68% | -17.72% | +101.07% | -52.75% | +85.77% | -7794.29% | -101.88% | +13.53% | -52.60% | -22.84% | +3447.85% | +21.71% | -5.59% | -31.09% | -56.52% | +26.37% | -37.92% | -33.79% | +27.21% | +5.92% | -7.45% | -9.93% | +36.10% | +3.41% | -23.11% | -11.37% | -9.95% | +26.22% | -15.49% | +23.78% | n/a |